Welcome to People on the move – March 2022, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and...
Read moreThe Therapeutic Goods Administration (TGA) has granted Lucentis (ranibizumab) an indication for retinopathy of prematurity (ROP), making it the first...
Read moreThe AFL has approved prescription sunglasses that Collingwood forward-ruck Mason Cox sought permission to wear in the wake of multiple...
Read moreAs Australian states and territories begin ramping up elective surgery capacity this week, the Australian Society of Ophthalmologists (ASO) is...
Read moreA new Federal Government report shows the volume of optometry services utilised under Medicare decreased sharply during lockdowns – down...
Read moreVision Australia is keen to remind eyecare professionals of its specialised employment services that can have a profound impact on...
Read moreZeiss is offering an increased trade-in discount on all models of its Humphrey Field Analyser 3 (HFA3) until 31 March...
Read moreDropout, hygiene compliance and other issues associated with contact lens wear will be the focus of a new study by...
Read moreData from patients with a subtype of AMD enrolled in Opthea’s Phase 2b clinical trial of OPT-302 in combination with...
Read moreAn Australian fugitive wanted so desperately by police they released his prescription and a $100,000 reward in the hope an...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited